Evidence map›Paper›PMID 36632075›Full record

ArticleTranslational and clinical pharmacology2022

Common

Jun Gi Hwang, Sae Im Jeong, Yu Kyong Kim, Yujin Lee, Sang Chun Ji, SeungHwan Lee, Min Kyu Park

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational and clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jun Gi HwangDepartment of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju 28644, Korea.ORCID https://orcid.org/0000-0002-0965-0531
Sae Im JeongDepartment of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju 28644, Korea.ORCID https://orcid.org/0000-0002-5299-4305
Yu Kyong KimDepartment of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju 28644, Korea.ORCID https://orcid.org/0000-0002-7868-1761
Yujin LeeDepartment of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju 28644, Korea.ORCID https://orcid.org/0000-0003-2373-6291
Sang Chun JiDepartment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.ORCID https://orcid.org/0000-0003-2858-1057
SeungHwan LeeDepartment of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.ORCID https://orcid.org/0000-0002-1713-9194
Min Kyu ParkDepartment of Clinical Pharmacology and Therapeutics, Chungbuk National University College of Medicine and Hospital, Cheongju 28644, Korea.ORCID https://orcid.org/0000-0002-9851-7555
Chungbuk National University Hospital · KRSeoul National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

P-glycoprotein (P-gp) is a transporter that plays an excretory role in epithelial cells. It is encoded by

Indexed as

ATP-Binding Cassette TransporterDipeptidyl-Peptidase IV InhibitorsP-glycoproteinSingle Nucleotide PolymorphismSodium-Glucose Transporter 2 Inhibitors

Identifiers

PMID36632075
PMCPMC9810488
OpenAlexW4313276961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.